Hillman Capital Management, Inc. Laboratory Corp Of America Holdings Transaction History

Hillman Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$274.82 - $308.34 $5.21 Million - $5.84 Million	-18,954 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$251.87 - $278.14 $11,082 - $12,238	-44 Reduced 0.23%	18,954 $5.23 Million
Q1 2021 May 14, 2021	SELL	$204.88 - $255.03 $8,604 - $10,711	-42 Reduced 0.22%	18,998 $4.85 Million
Q4 2020 Feb 12, 2021	BUY	$186.91 - $214.42 $16,448 - $18,868	88 Added 0.46%	19,040 $3.88 Million
Q3 2020 Nov 09, 2020	SELL	$167.03 - $201.3 $3,507 - $4,227	-21 Reduced 0.11%	18,952 $3.57 Million
Q2 2020 Aug 04, 2020	SELL	$113.31 - $182.44 $2,946 - $4,743	-26 Reduced 0.14%	18,973 $3.15 Million
Q1 2020 Apr 29, 2020	BUY	$104.32 - $195.28 $297,103 - $556,157	2,848 Added 17.63%	18,999 $2.4 Million
Q4 2019 Feb 14, 2020	BUY	$163.48 - $173.61 $2.64 Million - $2.8 Million	16,151 New	16,151 $2.73 Million

1.97M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.1B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hillman Capital Management, Inc. with notifications on news.